Pages that link to "Q33335165"
Jump to navigation
Jump to search
The following pages link to Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes (Q33335165):
Displaying 50 items.
- Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas (Q24603535) (← links)
- DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers (Q24642645) (← links)
- Mechanisms of hemorrhagic cystitis. (Q27686784) (← links)
- Activation and activities of the p53 tumour suppressor protein (Q28366563) (← links)
- Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells (Q28657964) (← links)
- Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation (Q28740315) (← links)
- Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model (Q30494652) (← links)
- A protein kinase associated with apoptosis and tumor suppression: structure, activity, and discovery of peptide substrates. (Q30998954) (← links)
- c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells (Q31018068) (← links)
- Gene MGMT and oligodendrogliomas. Fundamental data and short review of the literature (Q31019127) (← links)
- X-linked ectodermal dysplasia receptor is downregulated in breast cancer via promoter methylation (Q33658266) (← links)
- Identification of DBCCR1 as a suppressor in the development of lung cancer that is associated with increased DNA methyltransferase 1. (Q33779270) (← links)
- Biomarkers to Target Heterogeneous Breast Cancer Stem Cells (Q33811149) (← links)
- Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value (Q34099517) (← links)
- Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing (Q34228853) (← links)
- Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer (Q34288659) (← links)
- Methylation and colorectal cancer (Q34378429) (← links)
- Drug resistance in cancer: an overview. (Q34437369) (← links)
- Evolution of colorectal cancer: change of pace and change of direction. (Q34622521) (← links)
- Epigenetic gene silencing in cancer: the DNA hypermethylome (Q34646556) (← links)
- Epigenetic contributors to the discordance of monozygotic twins (Q34830485) (← links)
- The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females (Q34894017) (← links)
- Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort (Q35050475) (← links)
- The role of epigenetic modification in tumorigenesis and progression of pituitary adenomas: a systematic review of the literature (Q35075351) (← links)
- Epigenetic variability and the evolution of human cancer. (Q35094516) (← links)
- Cancer epigenetics (Q35551103) (← links)
- EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells (Q35558004) (← links)
- INK4a-ARF alterations in liver cell adenoma (Q35594804) (← links)
- Epigenomics and ovarian carcinoma. (Q35636575) (← links)
- Epigenomics of ovarian cancer and its chemoprevention (Q35711392) (← links)
- Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation. (Q35741879) (← links)
- DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps (Q35785652) (← links)
- The altered DNA methylation pattern and its implications in liver cancer (Q36109310) (← links)
- Array comparative genomic hybridization and its applications in cancer (Q36141621) (← links)
- DNA methylation profile at the DNMT3L promoter: a potential biomarker for cervical cancer (Q36148943) (← links)
- CIMP and colon cancer gets more complicated (Q36172680) (← links)
- Biologic characteristics of premalignant breast disease (Q36204798) (← links)
- Basic studies on epigenetic carcinogenesis of low-dose exposure to 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in vitro. (Q36281313) (← links)
- Malignant glioma: neuropathology and neurobiology. (Q36582393) (← links)
- Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers (Q36644616) (← links)
- Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. (Q36801625) (← links)
- DNA methylation in breast and colorectal cancers (Q36803766) (← links)
- Epigenomics and breast cancer (Q37078784) (← links)
- Restoration of the methylation status of hypermethylated gene promoters by microRNA-29b in human breast cancer: A novel epigenetic therapeutic approach (Q37102684) (← links)
- Application of DNA methylation biomarkers for endometrial cancer management (Q37266484) (← links)
- Correlation of MLH1 and MGMT methylation levels between peripheral blood leukocytes and colorectal tissue DNA samples in colorectal cancer patients (Q37269557) (← links)
- DNA methylation-mediated nucleosome dynamics and oncogenic Ras signaling: insights from FAS, FAS ligand and RASSF1A. (Q37273862) (← links)
- Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter. (Q37418067) (← links)
- Sensitive periods in epigenetics: bringing us closer to complex behavioral phenotypes (Q37626776) (← links)
- Epigenetic Drivers of Genetic Alterations (Q37797704) (← links)